热烈欢迎瑞士苏黎世联邦理工大学Andreas Hierlemann教授来我院学术交流
发布时间:2016-07-22  访问次数:323

Microtechnology and Microelectronics for Biological and Biomedical Applications
Prof. Andreas Hierlemann

ETH Zurich, D-BSSE, CH-4058 Basel, Switzerland

时间:2016年8月2日上午9:30
地点:东南院102

Biography:
Andreas Hierlemann completed his college education in chemistry at the University of Tübingen, Germany, and was awarded a Ph.D. degree in 1996. He then held Postdoctoral positions at Texas A & M University, College Station, TX, USA, in 1997, and at Sandia National Laboratories, Albuquerque, NM, USA, in 1998. In 1999, he joined the Department of Physics, ETH Zurich, Switzerland, where he was appointed Associate Professor in June 2004. In April 2008, he became a Full Professor in the Department of Biosystems Science and Engineering (D-BSSE), ETH Zurich, Basel. In 2009-2011 and 2011-2013, he was appointed Vice Department Head and Department Head of D-BSSE, respectively.
His research interests include the development and application of microsensor, microfluidic, and microelectronic technologies to address questions in biology and medicine with applications in the fields of systems biology, drug testing, personalized medicine, and neuroscience.
He has published more than 400 papers in international journals including Nature, PNAS, Chem Rev, AngewChemInt Ed, Nat Commun, Neuron, Proc IEEE, IEEE J Solid-State Circuits, and ISSCC, etc. He has four successful spin-off companies, Zurich Instruments, InSphero, Shift Devices, and MaxWell Biosystems.
Homepage:https://www.bsse.ethz.ch/bel/

Research:
His research, in general, is rooted in Physics and in the Engineering disciplines and is targeted at developing and applying microtechnological, microfluidic, and microelectronic technologies to address questions in biology and biomedicine.
Three major research lines encompass:
(1) CMOS Microsystems including microelectrode systems and chemo & biosensor systems
(2) Microfluidic Systems to address and handle single cells and microtissues
(3) Electrophysiology and Neuroscience.